Key Events This Week
Jul 13: Stock opens at Rs.130.70, down 0.34% on low volume
Jul 14: Sharp decline of 3.52% to Rs.126.10 amid sector weakness
Jul 15: Strong rebound of 3.85% to Rs.130.95 following positive quarterly results
Jul 16: Price stabilises at Rs.130.95 with muted volume
Jul 17: Crestchem gains 3.47% to close at Rs.135.50 despite downgrade to Sell
Monday, 13 July 2026: Modest Opening Amid Flat Sensex
Crestchem Ltd began the week at Rs.130.70, a slight decline of 0.34% from the previous Friday’s close of Rs.131.15. The volume was relatively low at 1,153 shares, reflecting subdued investor interest. The Sensex closed marginally higher by 0.01%, indicating a broadly stable market environment. Crestchem’s minor dip suggested cautious positioning ahead of upcoming corporate news.
Tuesday, 14 July 2026: Sharp Decline on Sector Weakness
The stock fell sharply by 3.52% to Rs.126.10, marking the week’s lowest close. This drop coincided with a broader market sell-off as the Sensex declined 0.67% amid concerns over sector valuations. Crestchem’s volume increased slightly to 1,191 shares, signalling some selling pressure. The decline reflected investor apprehension about the company’s valuation and near-term prospects in a volatile specialty chemicals sector.
Wednesday, 15 July 2026: Rebound Following Positive Quarterly Results
Crestchem rebounded strongly, gaining 3.85% to Rs.130.95 on relatively thin volume of 282 shares. This recovery was driven by the release of encouraging Q4 FY25-26 results, which showed record net sales of ₹10.23 crores and an improved operating profit margin of 13.78%. The positive operational metrics helped restore some investor confidence despite lingering concerns about annual profit contraction.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Thursday, 16 July 2026: Price Stabilises Ahead of Downgrade
The stock price remained unchanged at Rs.130.95 with moderate volume of 464 shares. The Sensex dipped 0.13%, reflecting a cautious market mood. Crestchem’s stability suggested investors were awaiting further clarity on the company’s outlook, which was soon to be impacted by a significant rating revision.
Friday, 17 July 2026: Downgrade to Sell Amid Valuation Concerns
Despite a downgrade by MarketsMOJO from Hold to Sell, Crestchem gained 3.47% to close at Rs.135.50 on heavy volume of 2,590 shares. The downgrade was prompted by a shift in valuation grade from attractive to fair, with the stock trading at a PE ratio of 14.50 and a price-to-book value of 3.97. While quarterly results showed operational strength, annual profit contraction and premium valuation multiples relative to peers raised caution.
The downgrade also highlighted the company’s micro-cap status, which entails higher volatility and liquidity risks. Nonetheless, Crestchem’s strong return on equity of 27.41% and return on capital employed of 32.81% underscore efficient capital utilisation. The stock’s 52-week trading range of Rs.73.01 to Rs.178.90 reflects significant price swings, with current levels closer to the upper band.
Is Crestchem Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Weekly Price Performance: Crestchem vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-13 | Rs.130.70 | -0.34% | 36,508.75 | +0.01% |
| 2026-07-14 | Rs.126.10 | -3.52% | 36,265.57 | -0.67% |
| 2026-07-15 | Rs.130.95 | +3.85% | 36,378.34 | +0.31% |
| 2026-07-16 | Rs.130.95 | +0.00% | 36,331.82 | -0.13% |
| 2026-07-17 | Rs.135.50 | +3.47% | 36,505.40 | +0.48% |
Key Takeaways
Positive Signals: Crestchem demonstrated operational resilience with record quarterly sales of ₹10.23 crores and improved profit margins. The stock outperformed the Sensex by 3.32% over the week, reflecting underlying strength despite market volatility. Strong ROE and ROCE ratios indicate efficient capital management and profitability.
Cautionary Signals: The downgrade to Sell by MarketsMOJO, driven by a shift from attractive to fair valuation, signals limited upside potential. The stock’s premium multiples relative to peers and recent annual profit contraction raise concerns about sustainability. Micro-cap status adds liquidity and volatility risks, which investors should consider carefully.
Conclusion
Crestchem Ltd’s week was marked by a blend of operational progress and valuation caution. While the company’s quarterly results and long-term returns remain commendable, the recent downgrade and valuation shift highlight challenges in near-term price appreciation. The stock’s 3.32% weekly gain outpaced the flat Sensex, yet the mixed signals suggest a need for measured investor scrutiny. Crestchem’s strong fundamentals coexist with valuation and liquidity risks, underscoring a complex investment profile amid evolving sector dynamics.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
